The recent incorporation of immune checkpoint inhibitors targeting the PD-1 (programmed
cell death receptor 1) and CTLA-4 (cytotoxic T lymphocyte antigen 4) pathways into the …

The programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) immune
checkpoint proteins hold promise as diagnostic, prognostic, and therapeutic targets for …

The association between thyroid cancer and thyroid autoimmunity has long been suggested,
but remains to be elucidated for several decades. Here the data on this issue are updated by …

Cooccurrences of chronic lymphocytic thyroiditis (CLT) and thyroid cancer (DTC) have been
repeatedly reported. Both CLT and DTC, mainly papillary thyroid carcinoma (PTC), share …

Thyroid cancer (TC) is the most prevalent malignant neoplasm that affects the endocrine
system. Hashimoto's thyroiditis (HT), also known as chronic lymphocytic thyroiditis, is the …

In the last decades, many studies conducted in vitro, and in vivo, have shown that thyroid
autoimmunity and thyroid cancer (TC)(mainly papillary TC) can be concomitant, even if the …

Immune cells play critical roles in tumor prevention as well as initiation and progression.
However, immune-resistant cancer cells can evade the immune system and proceed to form …

Cancer and autoimmune diseases are often associated in the same individual. The
functional link between the immune system and cancer development is only partially known …

Simple Summary To capitalize on the revolutionary anticancer efficacy of immune
checkpoint inhibitors (ICPi) in an expanding list of tumors, including hematological …

Immune checkpoint inhibitors (ICIs) are a group of drugs employed in the treatment of
various types of malignant tumors and improve the therapeutic effect. ICIs blocks negative co …